Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression

European Journal of Pharmacology

Volumn 571, Issue 2-3, 2007, Pages 180-188

  Bhuiyan, Md Shenuarin ^a   Shibuya, Masatoshi ^a   Shioda, Norifumi ^a   Moriguchi, Shigeki ^a   Kasahara, Jiro ^a   Iwabuchi, Yosiharu ^a   Fukunaga, Kohji ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Cardioprotection; Ischemia reperfusion; Protein kinase B (Akt); VO(OPT)

Indexed keywords

BIM PROTEIN; BIS(1 OXY 2 PYRIDINETHIOLATO)OXOVANADIUM; CASPASE 3; CASPASE 7; CASPASE 9; FAS LIGAND; FLICE INHIBITORY PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN BAD; PROTEIN KINASE B; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-ASSOCIATED DEATH PROTEIN; BLOOD PRESSURE; CARDIOTONIC AGENTS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CORONARY VESSELS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FAS LIGAND PROTEIN; FORKHEAD TRANSCRIPTION FACTORS; LIGATION; MALE; MEMBRANE PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; ORGANOMETALLIC COMPOUNDS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 34548508418     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.05.046     Document Type: Article

References (36)

1. Aihara K., Hisa H., Sato T., Yoneyama F., Sasamori J., Yamaguchi F., Yoneyama S., Mizuno Y., Takahashi A., and Nagai A. Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury. Eur. J. Pharmacol. 404 (2000) 221-229
2. Bhanot S., McNeill J.H., and Bryer-Ash M. Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats. Hypertension 24 (1994) 625-632
3. Bhuiyan M.S., and Fukunaga K. Inhibition of HtrA2/Omi ameliorates heart dysfunction following ischemia/reperfusion injury in rat heart in vivo. Eur. J. Pharmacol. 557 (2007) 168-177
4. Boscolo P., Carmignani M., Volpe A.R., Felaco M., Del Rosso G., Porcelli G., and iuliano G. Renal toxicity and arterial hypertension in rats chronically exposed to vanadate. Environ. Med. 51 (1994) 500-503
5. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
6. Cantley Jr. L.C., Josephson L., Warner R., Yanagisawa M., Lechene C., and Guidotti G. Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle. J. Biol. Chem. 252 (1977) 7421-7423
7. Carmeli C., Tadmor O., Lifshitz Y., Ophir R., and Carmel S. Inhibition of chloroplast CF1-ATPase by vanadate. FEBS Lett. 299 (1992) 229-230
8. Cohen M.V., Yang X.M., and Downey J.M. Smaller infarct after preconditioning does not predict extent of early functional improvement of reperfused heart. Am. J. Physiol. Heart Circ. Physiol. 277 (1999) H1754-H1761
9. Dafnis E., Spohn M., Lonis B., Kurtzman N.A., and Sabatini S. Vanadate causes hypokalemic distal renal tubular acidosis. Am. J. Physiol. 262 (1992) F449-F453
10. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., and Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231-241
11. Dijkers P.F., Medema R.H., Lammers J.W.J., Koenderman L., and Coffer P.J. Expression of the pro-apoptotic Bcl02 family member Bim is regulated by the forkhead transcription factor FKHRL-1. Curr. Biol. 10 (2000) 1201-1204
12. Elberg G., Li J., and Shechter Y. Vanadium activates or inhibits receptor and non-receptor protein tyrosine kinases in cell-free experiments, depending on its oxidation state. J. Biol. Chem. 269 (1994) 9521-9527
13. Feng Q., Lu X., Jones D.L., Shen J., and Arnold M.O. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation 104 (2001) 700-704
14. Geraldes C.F., Castro M.M., Sherry A.D., and Ramasamy R. Influence of vanadate on glycolysis, intracellular sodium and pH in perfused rat hearts. Mol. Cell Biochem. 170 (1997) 53-63
15. Gottilieb R.A., and Engler R.L. Apoptosis in myocardial ischemia-reperfusion. Ann. N.Y. Acad. Sci 874 (1999) 412-426
16. Imanishi T., Murry C.E., Reinecke H., Hano T., Nishio I., Liles W.C., Hofsta L., Kim K., O'Brien K.D., Schwartz S.M., and Han D.K. Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc Res 48 (2000) 101-110
17. Kawano T., Fukunaga K., Takeuchi Y., Morioka M., Yano S., Hamada J., Ushio Y., and Miyamoto E. Neuroprotective effect of sodium orthovanadate on delayed neuronal death after transient forebrain ischemia in gerbil hippocampus. J. Cereb. Blood Flow Metab 21 (2001) 1268-1280
18. Kops G.J., and Burgering B.M. Anat. 197 4 (2000) 511-574
19. Liem D.A., Gho C.C., Gho B.C., Kazim S., Manintveld O.C., Verdouw D.D., and Duncker D.J. The tyrosine phosphatase inhibitor bis(maltolato)oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels. J. Pharmacol. Exp. Ther 309 (2004) 1256-1262
20. Llobet J.M., and Domingo J.L. Acute toxicity of vanadium compounds in rats and mice. Toxicol. Lett 23 (1984) 227-231
21. Matsui T., Tao J., del Monte F., Lee K.H., Li L., Picard M., Force T.L., Franke T.F., Hajjar R.J., and Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104 (2001) 330-335
22. Mehdi M.Z., and Srivastava A.K. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimetics. Archiv. Biochem. Biophys 440 (2005) 158-164
23. Michael L.H., Ballantyne C.M., Zachariah J.P., Gould K.E., Pocius J.S., Taffet G.E., Hartley C.J., Pham T.T., Daniel S.L., and Funk E. Myocardial infarction and remodeling in mice: effect of reperfusion. Am. J. Physiol. 277 (1999) 660-668
24. Ou H., Yan L., Mustafi D., Makinen M.W., and Brady M.J. The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor. J. Biol. Inorg. Chem 10 (2005) 874-886
25. Rasper D.M., Vaillancourt J.P., Hadano S., Houtzager V.M., Seiden I., Keen S.L., Tawa P., Xanthoudakis S., Nasir J., Martindale D., Koop B.F., Peterson E.P., Thornberry N.A., Huang J., MacPherson D.P., Black S.C., Hornung F., Lenardo M.J., Hayden M.R., Roy S., and Nicholson D.W. Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ 5 (1998) 271-288
26. Reul B.A., Amin S.S., Buchet J.P., Ongemba L.N., Crans D.C., and Brichard S.M. Effect of vanadium complexes with organic ligands on glocuse metabolism: a comparison study in diabetic rats. Br. J. Pharmacol 126 (1999) 467-477
27. Ronzani N., Stephan L., and Hasselbach W. Pressure effects on the binding of vanadate to the sarcoplasmic reticulum calcium transport enzyme. Eur. J. Biochem 201 (1991) 265-272
28. 2) coordination mode; in vitro and in vivo evaluations in rats. J. Inor. Biochem 80 (2000) 99-105
29. Sakurai H., Shimomura S., Fukuzawa K., and Ishizu K. Detection of oxovanadium (IV) and characterization of its ligand environment in subcellular fractions of the liver of rats treated with pentavalent vanadium (V). Biochem. Biophys. Res. Commun 96 (1980) 293-298
30. Sakurai H., Tsuchiya K., Nukatsuka M., Sofue M., and Kawada J. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats. J. Endocrinol 126 (1990) 241-459
31. Skurk C., Maatz H., Kim H.S., Yang J., Abid M.R., Aird W.C., and Walsh K. The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J. Biol. Chem 279 (2004) 1513-1525
32. Suhara T., Mano T., Oliveira B.E., and Walsh K. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ. Res 89 (2001) 13-19
33. Takada Y., Hashimoto M., Kasahara J., Aihara K., and Fukunaga K. Cytoprotective effect of sodium orthovanadate on ischemia/reperfusion-induced injury in the rat heart involves Akt activation and inhibition of fodrin breakdown and apoptosis. J. Pharmacol. Exp. Ther 311 (2004) 1249-1255
34. Takashi E., and Ashraf M. Pathologic assessment of myocardial cell necrosis and apoptosis after ischemia and reperfusion with molecular and morphological markers. J. Mol. Cell Cardiol 32 (2000) 209-224
35. Watanabe T., Awane Y., Ikeda S., Fujiwara S., Kubo K., Kikuchi T., Kusumoto K., Wakimasu M., and Fujino M. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats. Br. J. Pharmacol 114 (1995) 949-954
36. Zhao Z.Q., Velez D.A., Wang N.P., Hewan-Lowe K.O., Nakamura M., Guyton R.A., and Vinten-Johansen J. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 6 (2001) 279-290